🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study we will use a multi-modal imaging approach of MRS and fMRI to...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2014-01
Trial ID
NCT01929759
Treatments Being Tested
This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...
Status
Completed
Location
Spectrum Medical Group
Start Date
2011-11
Trial ID
NCT01475838
The primary objective of this study is to assess glomerular function before...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-15
Trial ID
NCT02246998
Phase IV, Single-Arm, Open-Label Study Evaluating Bone Mineral Density in H...
Status
Unknown
Location
Mills Clinical Research
Start Date
2016-07
Trial ID
NCT03275701
Treatments Being Tested
The SINNR study will evaluate the virologic efficacy (viral load \<50 copie...
Status
Unknown
Location
Vancouver ID Research and Care Centre Society
Start Date
2014-11
Trial ID
NCT02306577
Treatments Being Tested
Switch patients from Atripla to Stribild will be evaluated to see if patien...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02477527
Treatments Being Tested
The purpose of this trial is to demonstrate at W48 the non-inferiority of a...
Status
Terminated
Location
Hôpital la Salpêtrière
Start Date
2019-11-27
Trial ID
NCT04051970
Treatments Being Tested
Elvitegravir is an HIV-1 integrase inhibitor which is marketed in a fixed d...
Status
Completed
Location
CRCN, Radboud University Medical Center
Start Date
2015-02
Trial ID
NCT02325934
Treatments Being Tested
To investigate the pharmacokinetic drug-drug interaction potential of fixed...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-23
Trial ID
NCT02556268
This study will evaluate the noninferiority of Stribild® (elvitegravir/cobi...
Status
Completed
Location
Spectrum Medical Group
Start Date
2011-12
Trial ID
NCT01495702